Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-1,247,800
Closed -$207M 147
2015
Q1
$207M Hold
1,247,800
1.76% 23
2014
Q4
$209M Buy
1,247,800
+103,100
+9% +$16.1M 1.99% 17
2014
Q3
$172M Sell
1,144,700
-37,000
-3% -$5.52M 1.8% 20
2014
Q2
$172M Buy
1,181,700
+124,900
+12% +$17.7M 2.02% 19
2014
Q1
$163M Buy
1,056,800
+283,800
+37% +$44.8M 2.01% 18
2013
Q4
$119M Buy
+773,000
New +$111M 1.74% 18

Other funds holding PRGO

OrbiMed's PRGO Position: Q2 2015 in Review

OrbiMed sold out of Perrigo (PRGO) in Q2 2015, closing a stake of 1,247,800 shares — an estimated $207M sold.

OrbiMed first reported a position in PRGO in Q4 2013 and held it in 6 quarters. The position peaked at $209M in Q4 2014. 577 funds tracked by Wall St. Rank hold PRGO as of Q2 2015.

  • OrbiMed reported no remaining Perrigo position as of Q2 2015 after selling out during the quarter.
  • OrbiMed sold 1,247,800 Perrigo shares in Q2 2015, an estimated $207M.
  • OrbiMed first reported a position in Perrigo in Q4 2013 and held it in 6 quarters.
  • OrbiMed's Perrigo position peaked at $209M in Q4 2014.
  • 577 funds tracked by Wall St. Rank held Perrigo as of Q2 2015.

Based on OrbiMed's 13F filing for Q2 2015, filed 14 Aug 2015.